iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.
BörsenkürzelISPC
Name des UnternehmensiSpecimen Inc
IPO-datumJun 17, 2021
CEOMr. Robert Bradley Lim
Anzahl der mitarbeiter24
WertpapierartOrdinary Share
GeschäftsjahresendeJun 17
Addresse8 Cabot Road
StadtWOBURN
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl08101
Telefon17813016700
Websitehttps://www.ispecimen.com/
BörsenkürzelISPC
IPO-datumJun 17, 2021
CEOMr. Robert Bradley Lim
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten